A Reuters Pharma conversation with EY: smart reviewing and payment outcomes
pharmaphorum
NOVEMBER 23, 2022
We looked at the areas of rare diseases, cell and gene therapy, vaccines – loads of different perspectives. EY was also running demos of EY’s Smart Reviewer, a transformational approach to reviewing promotional materials of life sciences companies. Smart reviewing: utilising AI and ML.
98 
Let's personalize your content